Equities

Techno Medica Co Ltd

6678:TYO

Techno Medica Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,810.00
  • Today's Change9.00 / 0.50%
  • Shares traded1.20k
  • 1 Year change-26.27%
  • Beta0.1149
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Techno Medica Co Ltd grew revenues 9.78% from 9.37bn to 10.28bn while net income improved 17.15% from 1.15bn to 1.35bn.
Gross margin49.98%
Net profit margin11.53%
Operating margin15.67%
Return on assets6.96%
Return on equity8.18%
Return on investment8.04%
More ▼

Cash flow in JPYView more

In 2024, cash reserves at Techno Medica Co Ltd fell by 3.16bn. However, the company earned 1.14bn from its operations for a Cash Flow Margin of 11.11%. In addition the company used 100.72m on investing activities and also paid 4.21bn in financing cash flows.
Cash flow per share181.53
Price/Cash flow per share12.18
Book value per share1,962.83
Tangible book value per share1,953.84
More ▼

Balance sheet in JPYView more

Techno Medica Co Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio5.44
Quick ratio4.51
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 13.33% and 26.85%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)3.29%
Div growth rate (5 year)7.67%
Payout ratio (TTM)39.41%
EPS growth(5 years)6.18
EPS (TTM) vs
TTM 1 year ago
14.59
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.